Virios Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details
Uncategorized
- Pay vs Performance Disclosure
- Insider Trading Arrangements

Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Share (Details)

v3.24.1.1.u2

Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Share (Details)			3 Months Ended
	May 01, 2024 $ / shares	Nov. 02, 2023 D $ / shares	Mar. 31, 2024 shares	Mar. 31, 2023 shares	Jul. 14, 2023 USD ($)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Consecutive business days \| D		30
Bid price per share \| $ / shares		$ 1.00
Threshold business days		10 days
Additional compliance period		180 days
Subsequent Events.
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Bid price per share \| $ / shares	$ 1.00
Capital on Demand Sales Agreement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Aggregate offering price \| $					$ 6,700,000
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities \| shares			2,319,422	1,912,147
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities \| shares			193,875	672,500

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represent the information pertaining to additional compliance period.

+ References

No definition available.

+ Details

Name:	viri_AdditionalCompliancePeriod
Namespace Prefix:	viri_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum aggregate offering price of stock that company can offer in sale agreement.

+ References

No definition available.

+ Details

Name:	viri_SaleOfStockMaximumAggregateOfferingPrice
Namespace Prefix:	viri_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents threshold bid price per share.

+ References

No definition available.

+ Details

Name:	viri_ThresholdBidPricePerShare
Namespace Prefix:	viri_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Threshold consecutive business days.

+ References

No definition available.

+ Details

Name:	viri_ThresholdConsecutiveBusinessDays
Namespace Prefix:	viri_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Threshold consecutive prior business days.

+ References

No definition available.

+ Details

Name:	viri_ThresholdConsecutivePriorBusinessDays
Namespace Prefix:	viri_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=viri_CapitalOnDemandSalesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: